研究・業績

ページタイトル画像

原著論文・症例報告

2021年

  1. Tateishi K, Saito Y, Kitahara H, Takaoka H, Kondo Y, Nakayama T, Fujimoto Y, Kobayashi Y. Vasospastic angina and overlapping cardiac disorders in patients resuscitated from cardiac arrest. Heart Vessels. 2021 Mar;36(3):321-329.

  2. Deguchi Y, Saito Y, Nakao M, Shiraishi H, Sakamoto N, Kobayashi S, Kobayashi Y. Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease. Heart Vessels. 2021 Mar;36(3):315-320.

  3. Wolff G, Shamekhi J, Al-Kassou B, Tabata N, Parco C, Klein K, Maier O, Sedaghat A, Polzin A, Sugiura A, Jung C, Grube E, Westenfeld R, Icks A, Zeus T, Sinning JM, Baldus S, Nickenig G, Kelm M, Veulemans V. Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients. Clin Res Cardiol. 2021 Mar;110(3):368-376.

  4. Sugiura A, Wilde N, Sedaghat A, Becher MU, Kelm M, Baldus S, Nickenig G, Veulemans V, Tiyerili V. Risk of mortality following transcatheter aortic valve replacement for low-flow low-gradient aortic stenosis. Clin Res Cardiol. 2021 Mar;110(3):391-398.

  5. Sugiura A, Weber M, Tabata N, Goto T, Treede H, Grube E, Werner N, Nickenig G, Sinning JM. Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation. Catheter Cardiovasc Interv. 2021;98(3):E412-E419.

2020年

  1. Kang G, Sarraju A, Nishi T, Rogers I, Tremmel JA, Kim JB. Spontaneous coronary artery dissection and ST-elevation myocardial infarction in an anomalous left anterior descending artery. JACC: Case Reports. 2020 ; 2 (1), 72-76.

  2. Daniels D, Pargaonkar V, Nishi T, Tremmel JA. Antegrade Dissection Re-Entry After Subintimal Wiring of an Occluded Vessel from Spontaneous Coronary Artery Dissection. JACC: Case Reports.2020 ;2 (1), 45-50.

  3. Pargaonkar VS, Lee JH, Chow EKH, Nishi T, Ball RL, Kobayashi Y, Kimura T, Lee DP, Stefanick ML, Fearon WF, Yeung AC, Tremmel JA. Dose-Response Relationship Between Intracoronary Acetylcholine and Minimal Lumen Diameter in Coronary Endothelial Function Testing of Women and Men With Angina and No Obstructive Coronary Artery Disease. Circ Cardiovasc Interv. 2020 Apr;13(4):e008587.

  4. Arashi H, Kobayashi Y, Price MJ, Nishi T, Chambers JW, Seto AH, Sarembock IJ, Raveendran G, Jeremias A, Fearon WF. Diagnostic Accuracy of Nonhyperemic Pressure Ratios Using a Pressure Sensing Microcatheter: The ACIST-FFR Study. JACC Cardiovasc Interv. 2020 May 25;13(10):1272-1275.

  5. Tateishi K, Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Increased platelet inhibition after switching from prasugrel to low-dose ticagrelor in Japanese patients with prior myocardial infarction. J Cardiol. 2020 May;75(5):473-477.

  6. Saito Y, Kobayashi Y. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention. Cardiovasc Interv Ther. 2020;35:44-51.

  7. Saito Y, Kobayashi Y. Update on Antithrombotic Therapy after Percutaneous Coronary Intervention. Intern Med. 2020;59:311-21.

  8. Saito Y, Kobayashi Y, Fujii K, Sonoda S, Tsujita K, Hibi K, Morino Y, Okura H, Ikari Y, Honye J. Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2020;35:1-12.

  9. Saito Y, Kobayashi Y, Tanabe K, Ikari Y. Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective. Cardiovasc Interv Ther. 2020;35:19-29.

  10. Mori N, Saito Y, Saito K, Matsuoka T, Tateishi K, Kadohira T, Kitahara H, Fujimoto Y, Kobayashi Y. Relation of Plasma Xanthine Oxidoreductase Activity to Coronary Lipid Core Plaques Assessed by Near-Infrared Spectroscopy Intravascular Ultrasound in Patients with Stable Coronary Artery Disease. Am J Cardiol. 2020;125:1006-12.

  11. Saito Y, Kitahara H, Nishi T, Fujimoto Y, Kobayashi Y. Systemic Endothelial Dysfunction in Patients with Vasospastic and Microvascular Angina: Serum Uric Acid as a Marker of Reactive Hyperemia Index. Coron Artery Dis. 2020;31:565-6.

  12. Saito Y, Kitahara H, Shoji T, Nakayama T, Fujimoto Y, Kobayashi Y. Decreased Double Product at Rest in Patients with Severe Vasospasm. Heart Lung Circ. 2020 Oct;29(10):1511-1516.

  13. Saito Y, Shoji T, Tateishi K, Kitahara H, Fujimoto Y, Kobayashi Y. Mental Health Status in Patients Undergoing Intracoronary Acetylcholine Provocation Test. Adv Ther. 2020;37:3807-15.

  14. Napp LC, Cammann VL, Jaguszewski M, Szawan KA, Wischnewsky M, Gili S, Knorr M, Heiner S, Citro R, Bossone E, D'Ascenzo F, Neuhaus M, Franke J, Sorici-Barb I, Noutsias M, Burgdorf C, Koenig W, Kherad B, Sarcon A, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Karakas M, Pott A, Meyer P, Arroja JD, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Hauck C, Paolini C, Bilato C, Imori Y, Kato K, Kobayashi Y, et al. Coexistence and outcome of coronary artery disease in Takotsubo syndrome. Eur Heart J. 2020;41:3255-3268.

  15. Cammann VL, Szawan KA, Stähli BE, Kato K, Budnik M, Wischnewsky M, et al. Age-Related Variations in Takotsubo Syndrome. J Am Coll Cardiol. 2020; 75: 1869-1877.

  16. D'Ascenzo F, Gili S, Bertaina M, Iannaccone M, Cammann VL, Di Vece D, Kato K, et al. Impact of aspirin on takotsubo syndrome: a propensity score-based analysis of the InterTAK Registry. Eur J Heart Fail. 2020; 22: 330-337.

  17. Tabata N, Al-Kassou B, Sugiura A, Shamekhi J, Sedaghat A, Treede H, Tsujita K, Werner N, Grube E, Nickenig G, Sinning JM. Predictive factors and long-term prognosis of transcatheter aortic valve implantation-associated endocarditis. Clin Res Cardiol 2020;109(9):1165-1176.

  18. Shamekhi J, Sugiura A, Tabata N, Al-Kassou B, Weber M, Sedaghat A, Werner N, Grube E, Nickenig G, Sinning JM. Impact of Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC cardiovascular interventions 2020;13(9):1135-1137.

  19. Al-Kassou B, Kandt J, Lohde L, Shamekhi J, Sedaghat A, Tabata N, Weber M, Sugiura A, Fimmers R, Werner N, Grube E, Treede H, Nickenig G, Sinning JM. Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR. JACC cardiovascular interventions 2020;13(12):1471-1480.

  20. Kavsur K, Hupp H, Sugiura A, Öztürk C, Weber M, Nickenig G, Tiyerili V, Becher MU. Pulmonary capillary wedge pressure (PCWP) as prognostic indicator in patients undergoing transcatheter valve repair (TTVR) of severe tricuspid regurgitation. Int J Cardiol. 2020;318:32-38.

  21. Shamekhi J, Sugiura A, Tabata N, Al-Kassou B, Sedaghat A, Werner N, Grube E, Nickenig G, Sinning JM. Impact of tricuspid regurgitation in patients undergoing transcatheter aortic valve implantation. JACC cardiovascular interventions 2020;13(18):2137-2145.

  22. Tabata N, Al-Kassou B, Sugiura A, Kandt J, Shamekhi J, Stundl A, Zimmer S, Treede H, Ishii M, Tsujita K, Werner N, Nickenig G, Sinning JM. Prognostic impact of cancer history in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol 2020;109(10):1243-1250.

  23. Sugiura A, Weber M, Efstratios CI, Treede H, Sinning JM, Nickenig G. Neochord system as an alternative option upon transmitral pressure gradient elevation in the MitraClip procedure. JACC Cardiovascular Interventions 2020;13(5):e39-e40.

  24. Sugiura A, Oeztuerk C, Weber M, Sinning JM, Nickenig G. Staged grasping with the PASCAL device for mitral regurgitation with leaflet laceration. EuroIntervention. 2020;16(4):e303-e304.

  25. Sugiura A, Weber M, Treede H, Nickenig G. Aortic valve deformation during transcatheter mitral valve implantation. JACC Cardiovascular Interventions 2020;13(13):1603-1604.

  26. Sugiura A, Weber M, Tabata N, Goto T, Oeztuerk C, Hammerstingel C, Sinning JM, Werner N, Nickenig G. Prognostic impact of redo transcatheter mitral valve repair for recurrent mitral regurgitation. Am J Cardiol. 2020;130:123-129.

  27. Sueda S, Shinohara T, Takahashi N, Shite J, Shoji T, Akao M, Kijima Y, Masuyama T, Miyaji T, Yamamoto K, Iwasaki Y, Yoshida R, Nakamura S, Ogino Y, Kimura K, Sasai M, Suzuki H, Wakatsuki T, Asajima H, Teragawa H, Ishikawa T, Kitamura K, Oda T, Nakayama T, Kobayashi Y, Sunada D, Yamaki M, Nishizaki F, Tomita Y, Usuda K, Fujinaga H, Kuramitsu S, Andou K, Kiyooka T, Kadota K, Ishii Y, Ohtani H, Maekawa Y, Taguchi E, Nakao K, Kobayashi N, Seino Y, Nakagawa H, Saito Y, Komuro I, Sasaki Y, Ikeda S, Yamaguchi O, Kakutani A, Imanaka T, Ishihara M, Ishii M, Kaikita K, Tsujita K. Questionnaire in patients with aborted sudden cardiac death due to coronary spasm in Japan. Heart Vessels. 2020;35(12):1640-1649.

  28. Okada K, Honda Y, Kitahara H, Ikutomi M, Kameda R, Brooke Hollak M, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Kimura T; ABSORB Japan Investigators. Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial. Int J Cardiol Heart Vasc. 2020 Sep 4;31:100623.

  29. Onuma Y, Honda Y, Asano T, Shiomi H, Kozuma K, Ozaki Y, Namiki A, Yasuda S, Ueno T, Ando K, Furuya J, Hanaoka KI, Tanabe K, Okada K, Kitahara H, Ono M, Kusano H, Rapoza R, Simonton C, Popma JJ, Stone GW, Fitzgerald PJ, Serruys PW, Kimura T. Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years. JACC Cardiovasc Interv. 2020 Jan 13;13(1):116-127.

  30. Sugiura A, Kitahara H, Iwahana T, Suzuki N, Okada S, Miyauchi H, Kobayashi Y, Werner N. Association of heart failure duration with clinical prognosis in advanced heart failure. Clin Res Cardiol. 2020 Mar;109(3):350-357.

  31. Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Association between Achilles tendon xanthoma and severity of coronary artery disease in patients undergoing percutaneous coronary intervention. J Cardiol. 2020 Jun;75(6):654-658.

  32. Saito Y, Kobayashi Y, Fujii K, Sonoda S, Tsujita K, Hibi K, Morino Y, Okura H, Ikari Y, Honye J. Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2020;35(1):1-12.

  33. Saito Y, Kobayashi Y. Update on Antithrombotic Therapy after Percutaneous Coronary Intervention. Intern Med. 2020;59(3):311-321

  34. Saito Y, Kobayashi Y. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention. Cardiovasc Interv Ther. 2020;35(1):44-51.

  35. Sugiura A, Kitahara H, Iwahana T, Eguchi N, Okada S, Miyauchi H, Kobayashi Y, Werner N. Association of Heart Failure Duration with Clinical Prognosis in Advanced Heart Failure. Clin Res Cardiol. 2020;109(3):350-357.

  36. Sugiura A, Weber M, von Depka A, Tabata N, Shamekhi J, Al-Kassou B, Nickenig G, Werner N, Sinning JM, Sedaghat A. Outcomes of myocardial fibrosis in patients undergoing transcatheter aortic valve replacement. Eurointervention. 2020;15(16):1417-1423.

 

2019年

  1. Okuya Y, Saito Y, Takahashi T, Kishi K, Hiasa Y. Novel Predictors of Late Lumen Enlargement in Distal Reference Segments after Successful Recanalization of Coronary Chronic Total Occlusion. Catheter Cardiovasc Interv. 2019;94:546-52.

  2. Okuya Y, Saito Y, Takahashi T, Kishi K. Impact of Elevated Serum Uric Acid Level on Target Lesion Revascularization After Percutaneous Coronary Intervention for Chronic Total Occlusion. Am J Cardiol. 2019;124:1827-32.

  3. Sueta D, Tabata N, Ikeda S, Saito Y, Ozaki K, Sakata K, Matsumura T, Yamamoto-Ibusuki M, Murakami Y, Jodai T, Fukushima S, Yoshida N, Kamba T, Araki E, Iwase H, Fujii K, Ihn H, Kobayashi Y, Minamino T, Yamagishi M, Maemura K, Baba H, Matsui K, Tsujita, K. Differential Predictive Factors For Cardiovascular Events in Patients With or Without Cancer History. Medicine (Baltimore). 2019;98:e17602.

  4. Tabata N, Weber M, Sugiura A, Oeztuerk C, Ishii M, Tsujita K, Nickenig G, Sinning JM. Impact of the leaflet-to-annulus index on residual mitral regurgitation in patients undergoing edge-to-edge mitral repair. JACC cardiovascular interventions 2019;12(24):2462-2472.

  5. Tabata N, Al-Kassou B, Sugiura A, Shamekhi J, Treede H, Tsujita K, Werner N, Grube E, Nickenig G, Sinning JM. Clinical Impact of the Platelet-to-Lymphocyte Ratio in Cancer Patients Undergoing Transcatheter Aortic Valve Implantation. J Am Coll Cardiol CardioOnc. 2019;1:159–169.

  6. Tokimasa S, Kitahara H, Nakayama T, Fujimoto Y, Shiba T, Shikama N, Nameki M, Himi T, Fukushima KI, Kobayashi Y. Multicenter research of bleeding risk between prasugrel and clopidogrel in Japanese patients with coronary artery disease undergoing percutaneous coronary intervention. Heart Vessels. 2019 Oct;34(10):1581-1588.

  7. Kitahara H, Mori N, Saito Y, Nakayama T, Fujimoto Y, Kobayashi Y. Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention. Heart Vessels. 2019 Oct;34(10):1595-1599.

  8. Tateishi K, Abe D, Suzuki K, Hamabe Y, Aonuma K, Sato A. Association Between Multivessel Coronary Artery Disease and Return of Spontaneous Circulation Interval in Acute Coronary Syndrome Patients with Out-of-Hospital Cardiac Arrest. Int Heart J. 2019;60:1043-1049.

  9. Sueta D, Tabata N, Ikeda S, Saito Y, Ozaki K, Sakata K, Matsumura T, Yamamoto-Ibusuki M, Murakami Y, Jodai T, Fukushima S, Yoshida N, Kamba T, Araki E, Iwase H, Fujii K, Ihn H, Kobayashi Y, Minamino T, Yamagishi M, Maemura K, Baba H, Matsui K, Tsujita, K. Differential Predictive Factors For Cardiovascular Events in Patients With or Without Cancer History. Medicine (Baltimore). 2019;98(44):e17602.

  10. Okuya Y, Saito Y, Takahashi T, Kishi K. Impact of Elevated Serum Uric Acid Level on Target Lesion Revascularization After Percutaneous Coronary Intervention for Chronic Total Occlusion. Am J Cardiol. 2019;124(12):1827-1832.

  11. Saito Y, Kobayashi Y. Percutaneous coronary intervention strategies in patients with acute myocardial infarction and multivessel disease: Completeness, timing, lesion assessment, and patient status. J Cardiol. 2019;74:95-101.

  12. Okuya Y, Saito Y, Takahashi T, Kishi K, Hiasa Y. Novel Predictors of Late Lumen Enlargement in Distal Reference Segments after Successful Recanalization of Coronary Chronic Total Occlusion. Catheter Cardiovasc Interv. 2019;94:546-52.

  13. Saito Y, Kitahara H, Nishi T, Fujimoto Y, Kobayashi Y. Decreased Resting Coronary Flow and Impaired Endothelial Function in Patients with Vasospastic Angina. Coron Artery Dis. 2019;30:291-6.

  14. Okuya Y, Saito Y, Sakai Y, Ishibashi I, Kobayashi Y. Impact of tissue protrusion after coronary stenting in patients with ST-segment elevation myocardial infarction. Int J Cardiovasc Imaging. 2019;35:401-7.

  15. Saito Y, Kobayashi Y. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention. J Cardiol. 2019;73:1-6.

  16. Saito Y, Kitahara H, Matsumiya G, Kobayashi Y. Preoperative Endothelial Function and Long-Term Cardiovascular Events in Patients Undergoing Cardiovascular Surgery. Heart Vessels. 2019;34:318-23.

  17. Saito Y, Kitahara H, Okuya Y, Nakayama T, Fujimoto Y, Kobayashi Y. Novel Predictor of Target Vessel Revascularization after Coronary Stent Implantation: Intraluminal Intensity of Blood Speckle on Intravascular Ultrasound. Catheter Cardiovasc Interv. 2019;93:604-10.

  18. Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Relation of Elevated Serum Uric Acid Level to Endothelial dysfunction in Patients with Acute Coronary Syndrome. J Atheroscler Thromb. 2019;26:362-7.

  19. Kato K, Gili S, Fabbian F, Manfredini R. Co-morbidities in takotsubo syndrome. ESC CardioMed (3 edn). Part 3, section 30, chapter 30.9.

  20. Kato K, Ishibashi I, Ghadri JR, Templin C. Biventricular takotsubo syndrome. Eur Heart J. 2019; 40: 2171.

  21. Kato K, Di Vece D, Cammann VL, Micek J, Szawan KA, Bacchi B, Lüscher TF, Ruschitzka F, Ghadri JR, Templin C. Takotsubo Recurrence –Morphological Types and Triggers and Identification of Risk Factors. J Am Coll Cardiol. 2019; 73: 982-984.

  22. Kato K, Templin C. Escape from the takotsubo octopus trap: liberation often temporary and readmission rates high. Eur Heart J Qual Care Clin Outcomes. 2019; 5: 88-89.

  23. Nishi T, Funabashi N, Ozawa K, Nishi T, Kamata T, Fujimoto Y, Kobayashi Y. Regional layer-specific longitudinal peak systolic strain using exercise stress two-dimensional speckle-tracking echocardiography for the detection of functionally significant coronary artery disease. Heart Vessels. 2019;34(8):1394-1403.

  24. Nishi T, Funabashi N, Fujimoto Y, Kobayashi Y. Simultaneous anterior and inferior myocardial infarction in a patient with a single coronary artery anomaly. Eur Heart J. 2019 May 3. pii: ehz262. doi: 10.1093/eurheartj/ehz262.

  25. Sugiura A, Weber M, Sinning JM, Werner N, Nickenig G. Provisional closure of an iatrogenic atrial septal defect for shunt reversal after transcatheter treatment of tricuspid regurgitation. J Invasive Cardiol. 2019;31(10):E298-E299.

  26. Kitahara H, Mori N, Saito Y, Nakayama T, Fujimoto Y, Kobayashi Y. Plaque Stabilization by Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor in a Patient With Familial Hypercholesterolemia Undergoing Percutaneous Coronary Intervention. Circ J. 2019;83(5):1084.

  27. Oka N, Kadohira T, Fujii K, Kitahara H, Fujimoto Y, Kobayashi Y. Microbubble contrast enhancement of neointima after drug-eluting stent implantation: an optical coherence tomography study. Heart Vessels. 2019;34(3):393-400.

  28. Saito Y, Kobayashi Y. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention. J Cardiol. 2019;73(1):1-6.

  29. Saito Y, Kitahara H, Matsumiya G, Kobayashi Y. Preoperative Endothelial Function and Long-Term Cardiovascular Events in Patients Undergoing Cardiovascular Surgery. Heart Vessels. 2019;34(2):318-323.

  30. Saito Y, Kitahara H, Okuya Y, Nakayama T, Fujimoto Y, Kobayashi Y. Novel Predictor of Target Vessel Revascularization after Coronary Stent Implantation: Intraluminal Intensity of Blood Speckle on Intravascular Ultrasound. Catheter Cardiovasc Interv. 2019;93(4):604-610.

  31. Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Relation of Elevated Serum Uric Acid Level to Endothelial dysfunction in Patients with Acute Coronary Syndrome. J Atheroscler Thromb. 2019;26(4):362-367.

  32. Ohno Y, Kitahara H, Fujii K, Kohno Y, Ariyoshi N, Nishi T, Fujimoto Y, Kobayashi Y. High residual platelet reactivity after switching from clopidogrel to low-dose prasugrel in Japanese patients with end-stage renal disease on hemodialysis. J Cardiol. 2019;73(1):51-57.

  33. Sugiura A, Weber M, Sinning JM, Werner N, Nickenig G. Staged Transcatheter Valve Repair via MitraClip XTR after Cardioband for Tricuspid Regurgitation. EHJ cardiovascular imaging 2019;20(1):118.

  34. Sugiura A, Abe R, Nakayama T, et al. Predictors of successful weaning from veno-arterial extracorporeal membrane oxygenation after coronary revascularization for acute myocardial infarction complicated by cardiac arrest: A retrospective multicenter study. Shock. 2019;51(6):690-697.

2018年

  1. Kato K, Cammann VL, Wischnewsky M, Ghadri JR, Templin C. Reply: Prevalence of Diabetes Mellitus in Patients with Takotsubo Syndrome, Precipitated by Nonphysical or No Triggers. J Am Coll Cardiol. 2018; 72: 2942-2944.

  2. Ghadri JR*, Kato K* (*First two authors equally contributed to this work), Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, Münzel T, Knorr M, Heiner S, D'Ascenzo F, Franke J, Sarcon A, Napp LC, Jaguszewski M, Noutsias M, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschöpe C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuß G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El-Battrawy I, Akin I, Borggrefe M, Horowitz J, Kozel M, Tousek P, Widimský P, Gilyarova E, Shilova A, Gilyarov M, Winchester DE, Ukena C, Bax JJ, Prasad A, Böhm M, Lüscher TF, Ruschitzka F, Templin C. Long-Term Prognosis of Patients With Takotsubo Syndrome. J Am Coll Cardiol. 2018; 72: 874-882.

  3. Kato K, Sakai Y, Ishibashi I, Himi T, Fujimoto Y, Kobayashi Y. Predictors of in-hospital cardiac complications in patients with Takotsubo syndrome. Heart Vessels. 2018; 33: 1214-1219.

  4. Kato K, Kobayashi Y. Author's reply. J Cardiol. 2018; 72: 177.

  5. Nishi T, Kitahara H, Fujimoto Y, Nakayama T, Nagashima K, Hanaoka H, Kobayashi Y. Intravenous nicorandil versus adenosine for fractional flow reserve measurement: a crossover, randomized study. Heart Vessels. 2018;33(12):1570-1575.

  6. Ichimoto E, Kadohira T, Nakayama T, De Gregorio J. Efficacy of radiation dose reduction due to real-time monitoring and visualization of peak skin dose during coronary angiography and percutaneous coronary intervention. Catheter Cardiovasc Interv. 2018;91:717-722.

  7. Ichimoto E, Arnofsky A, Wilderman M, Goldweit R, De Gregorio J. Early Mortality and Safety After Transcatheter Aortic Valve Replacement Using the SAPIEN 3 in Nonagenarians. J Geriatr Cardiol. 2018;15:387-393.

  8. Kitahara H, Mastuura K, Sugiura A, Yoshimura A, Muramatsu T, Tamura Y, Nakayama T, Fujimoto Y, Matsumiya G, Kobayashi Y. Recurrence of Left Ventricular Outflow Tract Obstruction Requiring Alcohol Septal Ablation after Transcatheter Aortic Valve Implantation. Case Rep Cardiol. 2018;2018:5026190.

  9. Tateishi K, Saito Y, Kitahara H, Shoji T, Kadohira T, Nakayama T, Fujimoto Y, Kobayashi Y. Safety and usefulness of acetylcholine provocation test in patients with no culprit lesions on emergency coronary angiography. Int J Cardiol. 2018;269:27-30.

  10. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Feasibility and Safety of Outpatient Cardiac Catheterization with Intracoronary Acetylcholine Provocation Test. Heart Vessels. 2018;33:846-52.

  11. Nishi T, Kitahara H, Saito Y, Nishi T, Nakayama T, Fujimoto Y, Matsumiya G, Kobayashi Y. Invasive Assessment of Microvascular Function in Patients With Valvular Heart Disease. Coron Artery Dis. 2018;29:223-9.

  12. Saito Y, Kobayashi Y. Intracoronary Acetylcholine Provocation Test via Coronary Bypass Graft. Circ J. 2018;82:1963-4.

  13. Sugiura A, Kitahara H, Fujii K, Fujimoto Y, Kobayashi Y. Aortic Dissection Resulting in Simultaneous Bilateral Coronary Invasion via Different Mechanisms on Intravascular Ultrasonography. Circ J. 2018;82:2383-2384.

  14. Ichimoto E, Kadohira T, Nakayama T, De Gregorio J. Efficacy of radiation dose reduction due to real-time monitoring and visualization of peak skin dose during coronary angiography and percutaneous coronary intervention. Catheter Cardiovasc Interv. 2018 ;91(4):717-722.

  15. Ichimoto E, Kadohira T, Nakayama T, De Gregorio J. Long-Term Clinical Outcomes after Treatment with Excimer Laser Coronary Atherectomy for In-Stent Restenosis of Drug-Eluting Stent. Int Heart J. 2018 ;59(1):14-20.

  16. Delamination of novel ultrathin bioabsorbable abluminal polymer of platinum chromium everolimus-eluting stent. Fujimoto Y, Kobayashi Y, Kato K, Yamaguchi M. Cardiovasc Interv Ther. 2018 Jan;33(1):97-98.

  17. Tateishi K, Abe D, Iwama T, Hamabe Y, Aonuma K, Sato A. Clinical value of ST-segment change after return of spontaneous cardiac arrest and emergent coronary angiography in patients with out-of-hospital cardiac arrest: Diagnostic and therapeutic importance of vasospastic angina. Eur Heart J Acute Cardiovasc Care. 2018;7(5):405-413.

  18. Wakabayashi S, Kitahara H, Nishi T, Sugimoto K, Nakayama T, Fujimoto Y, Ariyoshi N, Kobayashi Y. Platelet inhibition after loading dose of prasugrel in patients with ST-elevation and non-ST-elevation acute coronary syndrome. Cardiovasc Interv Ther. 2018;33(3):239-246.

  19. Kato K, Kobayashi Y. Is myocardial bridging transient in patients with takotsubo syndrome? - Reply. J Cardiol. 2018;71(1):110.

  20. Ichimoto E, Kadohira T, Nakayama T, De Gregorio J. Efficacy of radiation dose reduction due to real-time monitoring and visualization of peak skin dose during coronary angiography and percutaneous coronary intervention. Catheter Cardiovasc Interv 2018;91(4):717-722.

  21. Fujimoto Y, Kobayashi Y, Kato K, Yamaguchi M. Delamination of novel ultrathin bioabsorbable abluminal polymer of platinum chromium everolimus-eluting stent. Cardiovasc Interv Ther. 2018;33(1):97-98.

2017年

  1. Okuya Y, Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Intraluminal Intensity of Blood Speckle on Intravascular Ultrasound, a Novel Predictor of Periprocedural Myocardial Injury After Coronary Stenting. Am J Cardiol. 2017;120:1084-9.

  2. Saito Y, Kitahara H, Matsumiya G, Kobayashi Y. Preoperative Assessment of Endothelial Function for Prediction of Adverse Events After Cardiovascular Surgery. Circ J. 2017;82:118-22.

  3. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Relation between severity of myocardial bridge and vasospasm. Int J Cardiol. 2017;248:34-8.

  4. Kitahara H, Okada K, Kimura T, Yock PG, Lansky AJ, Popma JJ, Yeung AC, Fitzgerald PJ, Honda Y. Impact of Stent Size Selection on Acute and Long-Term Outcomes After Drug-Eluting Stent Implantation in De Novo Coronary Lesions. Circ Cardiovasc Interv 2017;10:e004795.

  5. Successful delivery of polytetrafluoroethylene-covered stent using rapid exchange guide extension catheter. Fujimoto Y, Tonoike N, Kobayashi Y. Cardiovasc Interv Ther. 2017 Apr ;32(2):142-145.

  6. Okuya Y, Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Intraluminal intensity of blood speckle on intravascular ultrasound, a novel predictor of periprocedural myocardial injury after coronary stenting. Am J Cardiol 2017;120:1084–1089.

  7. Kato K, Lyon AR, Ghadri JR, Templin C. Takotsubo syndrome: aetiology, presentation and treatment. Heart. 2017 Sep;103(18):1461-1469.

  8. Kato K, Kitahara H, Saito Y, Fujimoto Y, Sakai Y, Ishibashi I, Himi T, Kobayashi Y. Impact of myocardial bridging on in-hospital outcome in patients with takotsubo syndrome. J Cardiol. 2017;70(6):615-619.

  9. Kato K, Daimon M, Ishibashi I, Kobayashi Y. Myocardial Edema in Takotsubo Syndrome - Serial Cardiovascular Magnetic Resonance Imaging of the Natural Course. Circ J. 2017;81(9):1368-1369.

  10. Saito Y, Kitahara H, Matsumiya G, Kobayashi Y. Preoperative Assessment of Endothelial Function for Prediction of Adverse Events After Cardiovascular Surgery. Circ J. 2017;82(1):118-122.

  11. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Relation between severity of myocardial bridge and vasospasm. Int J Cardiol. 2017; 248: 34-8.

  12. Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Night-time blood pressure variability negatively correlated with reactive hyperemia index. Int J Cardiol. 2017; 230: 332-4.

  13. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery. Heart Vessels. 2017; 32: 685-9.Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Paroxysmal atrial fibrillation during intracoronary acetylcholine provocation test. Heart Vessels. 2017; 32: 902-8.

  14. Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Diagnostic Accuracy of Intraluminal Blood Speckle Intensity on Intravascular Ultrasound for Physiological Assessment of Coronary Artery Stenosis. Coron Artery Dis. 2017;28:145-50.

  15. Nishi T, Ariyoshi N, Nakayama T, Fujimoto Y, Sugimoto K, Wakabayashi S, Hanaoka H, Kobayashi Y. Impact of chronic kidney disease on platelet inhibition of clopidogrel and prasugrel in Japanese patients. J Cardiol. 2017 ;69(5):752-755.

  16. Kitahara H, Waseda K, Sakamoto K, Yamada R, Huang CC, Nakatani D, Sakata K, Kawarada O, Yock PG, Matsuyama Y, Yokoi H, Nakamura M, Muramatsu T, Nanto S, Fitzgerald PJ, Honda Y. Impact of Attenuated-Signal Plaque Observed by Intravascular Ultrasound on Vessel Response After Drug-Eluting Stent Implantation. Atherosclerosis 2017;259:68-74.

  17. Kadohira T, Mintz GS, Souza CF, Witzenbichler B, Metzger DC, Rinaldi MJ, Mazzaferri EL Jr, Duffy PL, Weisz G, Stuckey TD, Brodie BR, Crowley A, Kirtane AJ, Stone GW, Maehara A. Impact of Chronic Statin Therapy on Clinical Presentation and Underlying Lesion Morphology in Patients Undergoing Percutaneous Intervention: An ADAPT-DES IVUS Substudy. Coron Artery Dis. 2017; 28(3):218-224.

  18. Kadohira T, Kobayashi Y. Intravascular ultrasound-guided drug-eluting stent implantation.Cardiovasc Interv Ther. 2017;32(1):1-11.

  19. Fujimoto Y, Tonoike N, Kobayashi Y.Successful delivery of polytetrafluoroethylene-covered stent using rapid exchange guide extension catheter.Cardiovasc Interv Ther. 2017 ;32(2):142-145.

  20. Kato K, Kobayashi Y. Validation of proposed risk stratification system for in-hospital cardiac complications in patients with takotsubo syndrome. ESC Heart Fail. 2017;4(1):78.

  21. Takahara M, Kitahara H, Nishi T, Miura K, Miyayama T, Sugimoto K, Nakayama T, Fujimoto Y, Kobayashi Y. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study. Int J Cardiovasc Imaging. 2017;33(1):25-30.

  22. Nishi T, Ariyoshi N, Nakayama T, Fujimoto Y, Sugimoto K, Wakabayashi S, Hanaoka H, Kobayashi Y. Impact of chronic kidney disease on platelet inhibition of clopidogrel and prasugrel in Japanese patients. J Cardiol. 2017;69(5):752-755.

  23. Nishi T, Kitahara H, Fujimoto Y, Nakayama T, Sugimoto K, Takahara M, Kobayashi Y. Comparison of 3-dimensional and 2-dimensional quantitative coronary angiography and intravascular ultrasound for functional assessment of coronary lesions. J Cardiol. 2017;69(1):280-286.

  24. Fujimoto Y, Tonoike N, Kobayashi Y. Successful delivery of polytetrafluoroethylene-covered stent using rapid exchange guide extension catheter. Cardiovasc Interv Ther. 2017;32(2):142-145.

2016年

  1. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Predictive value of coronary artery dilation response to nitrate for a positive intracoronary acetylcholine provocation test. Coron Artery Dis. 2016;27:551-5.

  2. Ohno Y, Okada S, Kitahara H, Nishi T, Nakayama T, Fujimoto Y, Kobayashi Y. Repetitive stent thrombosis in a patient who had resistance to both clopidogrel and prasugrel. Journal of Cardiology Cases. 2016;13(5):139-142.

  3. Sugiura A, Nakayama T, Takahara M, Sugimoto K, Hattori N, Abe R, Fujimoto Y, Oda S, Kobayashi Y. Combined use of extracorporeal membrane oxygenation and hemodialysis in the case of contrast-induced biphasic anaphylactic shock. Am J Emerg Med. 2016;34(9):1919.e1-2.

  4. Saito Y, Okada S, Funabashi N, Kobayashi Y. ANCA-negative eosinophilic granulomatosis with polyangitis (EGPA) manifesting as a large intracardiac thrombus and glomerulonephritis with angionecrosis. BMJ Case Rep. 2016. pii: bcr2016216520.

  5. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Intracoronary Acetylcholine Provocation Testing - Omission of the 20-µg Dose Is Feasible in Patients Without Coronary Artery Spasm in the Other Coronary Artery. Circ J. 2016;80:1820-3.

  6. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Predictive value of coronary artery dilation response to nitrate for a positive intracoronary acetylcholine provocation test. Coron Artery Dis. 2016;27:551-5.

  7. Saito Y, Takaoka H, Funabashi N, Ozawa K, Tamura Y, Saito M, Matsumiya G, Kobayashi Y. A case of very severe aortic stenosis due to unicuspid aortic valve mimicking bicuspid aortic valve with calcification on cardiac computed tomography. Int J Cardiol. 2016;215:516-8.

  8. Kato K, Kobayashi Y. Documentation of Focal Takotsubo Syndrome and Its Diagnostic Implication -Reply-. Circ J. 2016;80:2059.

  9. Kato K, Kitahara H, Fujimoto Y, Sakai Y, Ishibashi I, Himi T, Kobayashi Y. Prevalence and Clinical Features of Focal Takotsubo Cardiomyopathy. Circ J. 2016;80:1824-1829.

  10. Kato K, Daimon M, Sugiura A, Kobayashi Y. Transient Semi-Circumferential Mid-Ventricular Ballooning: An Atypical Variant of Takotsubo Cardiomyopathy. J Cardiol Cases. 2016;14:21-23.

  11. Kato K, Kitahara H, Kobayashi Y. Recurrence of Takotsubo Cardiomyopathy (Review). Int Cardiovasc Forum J. 2016;5:50-52.

  12. Nishi T, Takaoka H, Funabashi N, Nishimura M, Ohara O, Makiyama T, Ueda M, Kajiyama T, Kobayashi Y. Familial lamin A/C mutation cardiomyopathy with arrhythmia substrate detected by cardiac magnetic resonance imaging and electroanatomical mapping. Int J Cardiol. 2016 Apr 15;209:248-52.

  13. Nishi T, Kitahara H, Iwata Y, Fujimoto Y, Nakayama T, Takahara M, Sugimoto K, Kobayashi Y. Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5'-triphosphate in assessment of fractional flow reserve. J Cardiol. 2016; 68(6):512-516.

  14. Nishi T, Hasegawa A, Miyahara H, Nameki M, Kobayashi Y. In-stent accordion phenomenon. Int J Cardiol. 2016;220:129-30.

  15. Nishi T, Funabashi N, Ozawa K, Takahara M, Fujimoto Y, Kamata T, Kobayashi Y. Resting multilayer 2D speckle-tracking transthoracic echocardiography for the detection of clinically stable myocardial ischemic segments confirmed by invasive fractional flow reserve. Part 1: Vessel-by-vessel analysis. Int J Cardiol. 2016 Sep 1;218:324-32.

  16. Kitahara H, Waseda K, Yamada R, Otagiri K, Tanaka S, Kobayashi Y, Okada K, Kume T, Nakagawa K, Teramoto T, Ikeno F, Yock PG, Fitzgerald PJ, Honda Y. Acute stent recoil and optimal balloon inflation strategy: an experimental study using real-time optical coherence tomography. EuroIntervention 2016;12:e190-198.

  17. Kitahara H, Okada K, Tanaka S, Yang HM, Miki K, Kobayashi Y, Kimura T, Luikart H, Yock PG, Yeung AC, Fitzgerald PJ, Khush KK, Fearon WF, Honda Y. Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients. J Heart Lung Transplant 2016;35:752-759.

  18. Kitahara H, Waseda K, Yamada R, Sakamoto K, Yock PG, Fitzgerald PJ, Honda Y. Relative dose and vascular response after drug-eluting stent implantation: A dosimetric 3D-intravascular ultrasound study. Int J Cardiol 2016;204:211-217.

  19. Aoki Y, Ishikawa K, Miura K, Sugimoto K, Nakayama T, Fujimoto Y, Kobayashi Y. Protective effect of angiotensin II receptor blocker and calcium channel blocker on endothelial vasomotor function after everolimus-eluting stent implantation. J Cardiol. 2016;67:236-40.

2015年

  1. Saito Y, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Relation of Lipid Content of Coronary Plaque to Level of Serum Uric Acid. Am J Cardiol. 2015;116:1346-50.

  2. Nishi T, Ariyoshi N, Nakayama T, Fujimoto Y, Sugimoto K, Takahara M, Wakabayashi S, Koshizaka M, Hanaoka H, Kobayashi Y. Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in Japanese patients with stable coronary artery disease. Circ J. 2015;79(11):2439-44.

  3. Kitahara H, Honda Y, Fitzgerald PJ. Intravascular Ultrasound. In Textbook of PanVascular Medicine, 2nd edition. 2015:1379-1418.

  4. Saito Y, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Relation of Lipid Content of Coronary Plaque to Level of Serum Uric Acid. Am J Cardiol. 2015;116:1346-50.

  5. Saito Y, Takaoka H, Funabashi N, Hasegawa H, Ozawa K, Omoto A, Usui H, Shozu M, Kobayashi Y. Early pregnancy-associated cardiomyopathy complicated with a complete hydatidiform mole coexistent with a live fetus and exacerbated by induced abortion. Int J Cardiol. 2015;198:170-3.

  6. Kato K, Sakai Y, Ishibashi I, Kobayashi Y. Transient focal left ventricular ballooning: a new variant of Takotsubo cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2015;16(12):1406.

  7. Kato K, Sakai Y, Ishibashi I, Kobayashi Y. Reply: Takotsubo syndrome-induced acute myocardial infaction. Int J Cardiovasc Imaging. 2015;31:1019.

  8. Kato K, Sakai Y, Ishibashi I, Kobayashi Y. Mid-ventricular takotsubo cardiomyopathy preceding acute myocardial infaction. Int J Cardiovasc Imaging. 2015;31:821-2.

  9. Nishi T, Ariyoshi N, Nakayama T, Fujimoto Y, Sugimoto K, Takahara M, Wakabayashi S, Koshizaka M, Hanaoka H, Kobayashi Y. Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Japanese Patients With Stable Coronary Artery Disease. Circ J. 2015 Oct 23;79(11):2439-44.

  10. Miura K, Nakaya H, Kobayashi Y. Experimental assessment of effects of antiproliferative drugs of drug-eluting stents on endothelial cells. Cardiovasc Revasc Med. 2015 ;16 (6):344-7.

2014年

  1. Kato K, Sakai Y, Ishibashi I, Kobayashi Y. Recurrent mid-ventricular takotsubo cardiomyopathy. Int J Cardiovasc Imaging. 2014;30:1417-8.

  2. Kato K, Sakai Y, Ishibashi I, Kobayashi Y. Recurrent mid-ventricular takotsubo cardiomyopathy. International Journal of Cardiovascular Imaging.Int J Cardiovasc Imaging. 2014; 30:1417-8.

  3. Ohkubo K, Fujimoto Y, Iwata Y, Kitahara H, Kadohira T, Sugimoto K, Morino T, Kobayashi Y.Efficacy and safety of low-dose clopidogrel in Japanese patients after drug-eluting stent implantation: a randomized pilot trial. Heart Vessels. 2014;29:1-6.

  4. Fujimoto Y, Iwata Y, Yamamoto M, Kobayashi Y.Usefulness of Corsair microcatheter to cross stent struts in bifurcation lesions. Cardiovasc Interv Ther. 2014; 29:47-51

2013年

  1. Iwata Y, Fujimoto Y, Morino T, Sugimoto K, Ohkubo K, Kadohira T, Fukushima K, Kitahara H, Komuro I, Kobayashi Y.Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: a double-blind, randomized, placebo-controlled clinical trial. Am Heart J. 2013;165:408-14.

  2. Kitahara H, Fujimoto Y, Ishikawa K, Aoki Y, Iwata Y, Kadohira T, Morino T, Ohkubo K, Sugimoto K, Kobayashi Y.Recovery of endothelial function after sirolimus-eluting stent implantation: a pilot study. Angiology 2013;64:211-5.

2012年

  1. Fujimoto Y, Matsudo Y, Kobayashi Y. Successful delivery of polytetrafluoroethylene-covered stent through 5 French guiding catheter. J Invasive Cardiol. 2012; 24:E199-201.

2011年

  1. Kitahara H, Kobayashi Y, Iwata Y, Fujimoto Y, Komuro I.Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation. Am J Cardiol 2011;108:214-9.

  2. Kadohira T, Kobayashi Y, Iwata Y, Kitahara H, Komuro I.Coronary artery endothelial dysfunction associated with sleep apnea. Angiology 2011;62:397-400.

2010年

  1. Morino T, Kobayashi Y, Fujimoto Y, Himi T, Komuro I. Bare metal stent restenosis is benign clinical entity in Japanese patients. Int Heart J 2010;51:227-30.

  2. Ichimoto E, Kobayashi Y, Iijima Y, Kuroda N, Kohno Y, Komuro I. Long-term clinical outcomes after sirolimus-eluting stent implantation in dialysis patients. Int Heart J 2010;51:92-7.

  3. Fukushima K, Kobayashi Y, Kitahara H, Iwata Y, Kuroda N, Ooyama M, Nomura F, Komuro I. Effect of 450-mg loading dose of clopidogrel on platelet function in Japanese patients undergoing coronary stent placement. Heart Vessels 2010;25:182-6.

  4. Nakayama T, Komiyama N, Yokoyama M, Namikawa S, Kuroda N, Kobayashi Y, Komuro I. Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: A randomized prospective study using intravascular ultrasound. Int J Cardiol 2010;138:157-65.

  5. Fukushima K, Kobayashi Y, Kitahara H, Iwata Y, Kuroda N, Ooyama M, Kuwabara Y, Nomura F, Komuro I. Antiplatelet effect of 50-mg maintenance dose of clopidogrel compared to 200-mg ticlopidine: a preliminary study. Heart Vessels 2010;25:41-4.

  6. Ishio N, Kobayashi Y, Iwata Y, Kitahara H, Fukushima K, Asano T, Nakayama T, Kuroda N, Komuro I. Ubiquitous atherosclerosis in coronary arteries without angiographically significant stenosis.Heart Vessels 2010;25:35-40.

2009年

  1. Kadohira T, Kobayashi Y, Niitsuma Y, Imamaki M, Komuro I. Global ST-segment elevation associated with impending cardiac rupture during diagnostic cardiac catheterization. Int Heart J 2009;50:539-42.

  2. Nakayama T, Kobayashi Y, Takano H, Kuroda N, Hiroshima K, Komuro I. Silent very late thrombotic occlusion of sirolimus-eluting stent confirmed by directional coronary atherectomy. Circ J 2009;73:1762-4.

  3. Sugimoto K, Kobayashi Y, Miyahara H, Kuroda N, Funabashi N, Komuro I. Early stent thrombosis due to stent dislodgement in coronary artery aneurysm. Circ J 2009;73:1759-61.

  4. Sugimoto K, Kobayashi Y, Kuroda N, Komuro I. Cost analysis of sirolimus-eluting stents in Japanese health insurance system. Int Heart J 2009;50:723-30.

  5. Ichimoto E, Jo K, Kobayashi Y, Inoue T, Nakamura Y, Kuroda N, Miyazaki A, Komuro I. Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction. Circ J 2009;73:1669-73.

  6. Kitahara H, Kobayashi Y, Takebayashi H, Fujimoto Y, Nakamura Y, Kuroda N, Himi T, Miyazaki A, Haruta S, Komuro I, M. Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis. Circ J 2009;73:867-71.

  7. Asano T, Kobayashi Y, Fukushima K, Iwata Y, Kitahara H, Ishio N, Nakayama T, Kuroda N, Komuro I. Effect of balloon inflation time on expansion of sirolimus-eluting stent. Heart Vessels 2009;24:335-9.

  8. Kitahara H, Kobayashi Y, Takebayashi H, Nakamura Y, Kuroda N, Miyazaki A, Haruta S, Komuro I. Angiographic patterns of restenosis after sirolimus-eluitng stent implantation. Circ J 2009;73:508-11.

2008年

  1. Kitahara H, Kobayashi Y, Yamaguchi M, Ohkubo K, Nakayama T, Kuroda N, Komuro I. Damage to polymer of paclitaxel-eluting stent. Circ J 2008;72:1907-8.

  2. Kadohira T, Kobayashi Y, Asano T, Uehara M, Funabashi N, Nakayama T, Kuroda N, Komuro I. Fatal very late stent thrombosis in a young diabetic patient with severely diffuse coronary atherosclerosis. Int Heart J 2008;49:507-13.

  3. Ohkubo K, Kobayashi Y, Issei Komuro. Do Not Forget Vasospastic Angina in Patients With Chest Pain at Rest and No Significant Coronary Stenosis With Multidetector Computed Tomography. Am J Cardiol 2008;101:1519.

  4. Kitahara H, Kobayashi Y, Yamaguchi M, Fujimoto Y, Nameki M, Nakayama T, Kuroda N, Komuro I. Damage to Polymer of Undelivered Sirolimus-eluting Stents. J Invas Cardiol 2008;20:130-3

  5. Asano T, Kobayashi Y, Fukushima K, Iwata Y, Kitahara H, Ishio N, Kuroda N, Komuro I. Safety and efficacy of low-dose clopidogrel in Japanese patients undergoing coronary stenting. Circ J 2008;72:1707-8.

  6. Fukushima K, Kobayashi Y, Kitahara H, Iwata Y, Nakayama T, Kuroda N, Ooyama M, Nomura F, Komuro I. Effect of 150-mg vs 300-mg Loading Doses of Clopidogrel on Platelet Function in Japanese Patients Undergoing Coronary Stent Placement. Circ J 2008;72:1282-4.

  7. Iwata Y, Kobayashi Y, Fukushima K, Kitahara H, Asano T, Ishio N, Nakayama T, Kuroda N, Komuro I. Incidence of Premature Discontinuation of Antiplatelet Therapy After Sirolimus-eluting Stent Implantation. Circ J 2008;72:340-1.

  8. Kitahara H, Kobayashi Y, Fujimoto Y, Nakamura Y, Nakayama T, Kuroda N, Himi T, Miyazaki A, Komuro I. Late Stent Thrombosis in Patients Receiving Ticlopidine and Aspirin After Sirolimus-eluting Stent Implantation. Circ J 2008;72:168-9.

2007年

  1. Asano T, Kobayashi Y, Ohno M, Nakayama T, Kuroda N, Komuro I. Multivessel Coronary Artery Spasm Refractory to Intensive Medical Treatment. Angiology 2007;58:636-9

  2. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, Kuroda N, De Gregorio J, Kouno Y, Suzuki M, Haruta S, Komuro I. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007;71:1525-9.

  3. Fukushima K, Kobayashi Y, Okuno T, Nakamura Y, Sakakibara M, Nakayama T, Kuroda N, Miyazaki A, Shimizu Y, Komuro I. Incidence of side-effects of ticlopidine after sirolimus-eluting stent implantation. Circ J 2007;71:617-9.

2006年

  1. Kuriyama N, Kobayashi Y, Nakayama T, Kuroda N, Komuro I. Damage to polymer of a sirolimus-eluting stent. Circulation 2006;114:e586-7.

  2. Yoshida T, Kobayashi Y, Nakayama T, Kuroda N, Komiyama N, Komuro I. Stent deformity caused by coronary artery spasm. Circ J 2006;70:800-1.

  3. Asano T, Kobayashi Y, Mintz GS, Ishio N, Fujimaki S, Ogawa Y, Nakayama T, Kuroda N, Komuro I. Effect of plaque volume on subsequent vessel remodeling at edges of sirolimus-eluting stents. Am J Cardiol 2006;98:1041-4.

2003年

  1. Kuroda N, Kobayashi Y, Mintz GS, Komuro I. Multiple Ruptured Plaques: Serial Intravascular Ultrasound Examinations. Circulation 2003;108:e131-132.

  2. Kuroda K, Kobayashi Y, Desai K, Costantini C, Kobayashi M, Komuro I. Impact of change in prices of percutaneous coronary intervention devices on medical expenses. Circ J 2003;67:576-8.

2002年

  1. Kuriyama N, Kobayashi Y, Kuroda N, Desai K, Yamamoto Y, Komiyama N, Komuro I, Fitzgerald PJ. Effect of coronary stent overexpansion on lumen size and intimal hyperplasia at follow-up. Am J Cardiol 2002;89:1297-1299

  2. Kuroda N, Kobayashi Y, Nameki M, Kuriyama N, Kinoshita T, Okuno T, Yamamoto Y, Komiyama N, Masuda Y. Intimal hyperplasia regression from 6 to 12 months after stenting. Am J Cardiol 2002;89:869-872

2000年

  1. Kuroda N, Kobayashi Y, Yamamoto Y, Komiyama N, Masuda Y. Limited balloon expansion through the struts of the Palmaz-Schatz and NIR stents compared with the Multi-Link stent. Jpn Circ J. 2000;64:883-885.